Definitive Contract 75N91023C00004
Award Date
1/15/23
Potential Completion Date
1/14/28
Potential Value
$43M
Federal Agency
National Cancer Institute
Awardee
Agile Decision Sciences, LLC
Ultimate Awardee
Not listed
NAICS Category
518210 - Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
PSC Category
R702 - Support- Management: Data Collection
Federal Contract Vehicle
Set-Aside Type
Competitive 8(a)
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $30,206,398 definitive cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Asrc Federal Technology Solutions, LLC, an Alaskan Native Corporation-owned small disadvantaged business. The contract provides central support services for the NCI Center for Cancer Research's clinical trials portfolio over a base period of one year and four one-year option periods through January 2028. The...
This is a $171,423,571 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, Hispanic American-owned small business. The contract is for clinical trials sponsor and regulatory management support services to the NCI, its Center for Cancer Research (CCR), and CCR investigators. The services include compliance with regulations, regulatory support,...
This federal contract award is for clinical data management services in support of the National Cancer Institute (NCI) Center for Cancer Research (CCR). The contract was awarded to Agile Decision Sciences, LLC, an Alaskan Native Corporation-owned, minority-owned, and small disadvantaged business, as an 8(a) sole source award with a ceiling value of $21,651,719.00. The contract includes clinical data management services and is part of the larger Clinical Data Management for the National Cancer...
This is a $164,735,124.00 definitive, cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI) to Theradex Systems, Inc. to provide broad-based, centralized, and fully integrated operational, administrative, regulatory, information technology, and logistical support services for NCI-supported cancer clinical trials. The contract has a 10-year period of performance from May 1, 2022 to April 30, 2032 and is a re-competition of previous IDIQ contracts. The acquisition is...
This is a $15,747,412 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI) to CCS Associates, Inc., a woman-owned small business. The purpose of the contract is to provide regulatory services and technical support to the Division of Cancer Prevention (DCP) at NCI. The contract has a 12-month base period and four 12-month option periods extending through September 2028. Key tasks include regulatory correspondence tracking, safety activities, document management, and IT...
The National Cancer Institute (NCI) awarded a $55,311,391.18 cost-plus-fixed-fee contract to Technical Resources International, Inc. (TRI) for Drug Development Support for the Cancer Therapy Evaluation Program (CTEP). The contract, which runs through September 30, 2022, provides comprehensive clinical research support services to NCI, including clinical trials execution, regulatory support, research operations, and specialized scientific services. TRI, a minority-owned, woman-owned, and Hispanic...
This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
The National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, awarded a $69,925.40 firm fixed-price delivery order to Scientific Consulting Group Inc., a small, woman-owned business. The contract is for TASK ORDER 33: GEOSPATIAL APPROACHES TO CANCER CONTROL AND POPULATION SCIENCES - MEETING SUPPORT, which was set aside for small businesses. Scientific Consulting Group Inc. has multiple federal contract vehicles, including a $5.776 billion Blanket...
This $399,951 firm-fixed-price definitive contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the small business Care Progress LLC. The contract supports the development of "BIOMARKERAWARE: A NOVEL SYSTEM TO IMPROVE PRECISION ONCOLOGY" under the NCI's Small Business Innovation Research (SBIR) program, which is a set-aside for small businesses. Care Progress LLC, a for-profit limited liability company, has previously...
<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>